Institut Bergonié
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1923-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.bergonie.org
Convertases and Pancreatic Cancer: Cohort of Patients Treated for Pancreatic Adenocarcinoma
Not yet recruiting
- Conditions
- Pancreas Cancer
- First Posted Date
- 2024-11-26
- Last Posted Date
- 2024-11-26
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 50
- Registration Number
- NCT06705335
Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer.
Recruiting
- Conditions
- Prostate CancerMetastasis
- First Posted Date
- 2024-11-21
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 50
- Registration Number
- NCT06700057
- Locations
- 🇫🇷
Institut Bergonie, Bordeaux, France
Deep Learning for Histopathological Classification and Prognostication of Gynaecologic Smooth Muscle Tumours
Recruiting
- Conditions
- Stump
- Interventions
- Other: No intervention
- First Posted Date
- 2024-08-06
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 392
- Registration Number
- NCT06540846
- Locations
- 🇫🇷
Institut Bergonie, Bordeaux, France
Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures
Phase 2
Not yet recruiting
- Conditions
- Adult Soft Tissue SarcomaBiliary Tract CancerNon Small Cell Lung CancerColorectal CancerTriple Negative Breast Cancer
- Interventions
- First Posted Date
- 2023-10-16
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 120
- Registration Number
- NCT06084689
- Locations
- 🇫🇷
CHRU Poitiers, Poitiers, France
🇫🇷Centre Léon Bérard, Lyon, France
🇫🇷Institut Bergonié, Bordeaux, France
MEDI5752 in Patients With Mature Tertiary Lymphoid Structures Solid Tumors.
- First Posted Date
- 2023-06-05
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 102
- Registration Number
- NCT05888857
- Locations
- 🇫🇷
Institut Bergonie, Bordeaux, France
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Not Applicable
Recruiting
- Conditions
- Prostate CancerBreast CancerComorbidities and Coexisting ConditionsLung CancerColorectal Cancer
- Interventions
- Other: GERONTE
- First Posted Date
- 2023-02-09
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 720
- Registration Number
- NCT05720910
- Locations
- 🇫🇷
Hôpital Tenon AP-HP, Paris, France
🇫🇷Groupe Hospitalier Rance Emeraude, Saint-Malo, France
🇫🇷Centre Hospitalier de la Côte Basque, Bayonne, France
Evaluation of Cognitive Management for Chemobrain in Patients Treated for Breast Cancer.
Not Applicable
Active, not recruiting
- Conditions
- Breast Cancer
- Interventions
- Behavioral: Cognitive remediation
- First Posted Date
- 2023-01-19
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 164
- Registration Number
- NCT05690828
- Locations
- 🇫🇷
Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France
Cancer Risk Assessment in Patients With a Constitutional Alteration of the PTEN Gene
Recruiting
- Conditions
- PTEN Gene Mutation
- First Posted Date
- 2022-11-29
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 430
- Registration Number
- NCT05630105
- Locations
- 🇫🇷
Institut Bergonié, Comprehensive Cancer Center, Bordeaux, France
Lurbinectedin Combined With Durvalumab in Pre-treated Patients With Extensive Stage Small-cell Lung Cancer
Phase 2
Withdrawn
- Conditions
- Small Cell Lung CancerPlatinum-Sensitive Lung Small Cell CarcinomaExtensive-stage Small-cell Lung Cancer
- Interventions
- First Posted Date
- 2022-10-07
- Last Posted Date
- 2024-06-05
- Lead Sponsor
- Institut Bergonié
- Registration Number
- NCT05572476
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, France
Evaluation of Pretreatment Sarcopenia in Patients With Inoperable High-grade Ovarian Carcinoma as Part of Optimised Management
Not Applicable
Recruiting
- Conditions
- Ovarian Carcinoma
- Interventions
- Other: Presence of sarcopenia evaluated prior to neoadjuvant chemotherapy and during chemotherapy as part of optimised management(dietician and APA).
- First Posted Date
- 2022-06-13
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 25
- Registration Number
- NCT05415527
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, France
© Copyright 2025. All Rights Reserved by MedPath